0

    544611

    MAHALIFE

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Mahamaya Lifesciences Limited Share Price Today

    Investment Returns

    Over 1 Month 0.75% Over 3 Months 10.50% Over 6 Months -8.94% Over 1 Year 49.13%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    Mahamaya Lifesciences Limited fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 397.90
    • P/E Ratio (TTM) 24.23
    • Beta 0.53
    • Book Value / share 52.39
    • Return on equity 34.16%
    • EPS (TTM) 7.14
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 0.00
    info icon alternate text

    Mahamaya Lifesciences Limited Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 328.87
    Operating Expense 305.96
    Net Profit 16.72
    Net Profit Margin (%) 5.08
    Earnings Per Share (EPS) 8.43
    EBITDA 34.45
    Effective Tax Rate (%) 30.53
    Particulars MAR 2025 (Values in Cr)
    Revenue 264.15
    Operating Expense 249.80
    Net Profit 12.82
    Net Profit Margin (%) 4.85
    Earnings Per Share (EPS) 7.52
    EBITDA 25.84
    Effective Tax Rate (%) 25.72
    Particulars MAR 2024 (Values in Cr)
    Revenue 161.52
    Operating Expense 155.29
    Net Profit 5.47
    Net Profit Margin (%) 3.38
    Earnings Per Share (EPS) 43.80
    EBITDA 14.35
    Effective Tax Rate (%) 27.26
    Particulars MAR 2023 (Values in Cr)
    Revenue 137.02
    Operating Expense 132.18
    Net Profit 3.73
    Net Profit Margin (%) 2.72
    Earnings Per Share (EPS) 29.85
    EBITDA 9.15
    Effective Tax Rate (%) 28.40
    Particulars MAR 2022 (Values in Cr)
    Revenue 89.91
    Operating Expense 86.14
    Net Profit 2.80
    Net Profit Margin (%) 3.11
    Earnings Per Share (EPS) 22.44
    EBITDA 6.27
    Effective Tax Rate (%) 28.86
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 27.82
    ROE % 34.93
    ROCE % 25.79
    Total Debt to Total Equity 1.52
    EBITDA Margin 9.83
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 197.46
    ROE % 23.67
    ROCE % 21.04
    Total Debt to Total Equity 1.79
    EBITDA Margin 8.97
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 155.67
    ROE % 21.34
    ROCE % 20.05
    Total Debt to Total Equity 1.24
    EBITDA Margin 6.73
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 125.77
    ROE % 17.31
    ROCE % 15.20
    Total Debt to Total Equity 1.22
    EBITDA Margin 7.02
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 28.07
    ROE % 34.16
    ROCE % 25.56
    Total Debt to Total Equity 1.50
    EBITDA Margin 9.73
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 201.64
    ROE % 24.37
    ROCE % 21.29
    Total Debt to Total Equity 1.76
    EBITDA Margin 9.08
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 157.84
    ROE % 18.92
    ROCE % 17.89
    Total Debt to Total Equity 1.24
    EBITDA Margin 6.75
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 3.99
    Total Assets 188.35
    Total Liabilities 188.35
    Total Equity 49.42
    Share Outstanding 1
    Price to Book Ratio 0.00
    Return on Assets (%) 6.87
    Return on Capital (%) 12.04
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 3.01
    Total Assets 112.06
    Total Liabilities 112.06
    Total Equity 24.65
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 4.65
    Return on Capital (%) 6.58
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 3.04
    Total Assets 77.88
    Total Liabilities 77.88
    Total Equity 19.43
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 4.81
    Return on Capital (%) 8.56
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 1.36
    Total Assets 55.71
    Total Liabilities 55.71
    Total Equity 15.70
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 4.88
    Return on Capital (%) 7.81
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 3.91
    Total Assets 188.71
    Total Liabilities 188.71
    Total Equity 49.86
    Share Outstanding 1
    Price to Book Ratio 0.00
    Return on Assets (%) 6.79
    Return on Capital (%) 11.88
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.81
    Total Assets 112.36
    Total Liabilities 112.36
    Total Equity 25.18
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 4.86
    Return on Capital (%) 6.88
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 1.40
    Total Assets 78.27
    Total Liabilities 78.27
    Total Equity 19.71
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 4.76
    Return on Capital (%) 8.46
    Particulars MAR 2025 (Values in Cr)
    Net Income 17.35
    Cash from Operations 2.79
    Cash from Investing -8.28
    Cash from Financing 8.52
    Net change in Cash 0.76
    Free Cash Flow 11.66
    Particulars MAR 2024 (Values in Cr)
    Net Income 7.11
    Cash from Operations -21.47
    Cash from Investing -2.09
    Cash from Financing 24.34
    Net change in Cash -0.31
    Free Cash Flow -19.10
    Particulars MAR 2023 (Values in Cr)
    Net Income 5.09
    Cash from Operations 2.17
    Cash from Investing -2.85
    Cash from Financing 2.35
    Net change in Cash 0.62
    Free Cash Flow 5.07
    Particulars MAR 2022 (Values in Cr)
    Net Income 3.72
    Cash from Operations 3.36
    Cash from Investing -3.25
    Cash from Financing 1.37
    Net change in Cash 0.28
    Free Cash Flow 6.63
    Particulars MAR 2025 (Values in Cr)
    Net Income 17.26
    Cash from Operations -1.48
    Cash from Investing -4.43
    Cash from Financing 8.46
    Net change in Cash 0.68
    Free Cash Flow 3.55
    Particulars MAR 2024 (Values in Cr)
    Net Income 7.52
    Cash from Operations -21.41
    Cash from Investing -2.24
    Cash from Financing 24.25
    Net change in Cash -0.58
    Free Cash Flow -19.03
    Particulars MAR 2023 (Values in Cr)
    Net Income 5.20
    Cash from Operations 2.02
    Cash from Investing -2.77
    Cash from Financing 2.59
    Net change in Cash 0.62
    Free Cash Flow 4.92
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    EXCEL INDUSTRIES LTD. 890.00 14.79 0.65 1118.79 801.00 1438.00
    PUNJAB CHEM & CROP PROT L 1068.70 19.99 3.09 1310.23 875.90 1664.95
    DHANUKA AGRITECH LTD. 1070.85 16.36 3.40 4773.67 889.95 1960.00
    UPL LIMITED 600.30 26.87 1.46 50659.62 563.25 812.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    BAYER CROPSCIENCE LTD 4117.00 26.85 6.23 18502.66 4030.00 6539.95
    EXCEL INDUSTRIES LTD. 890.00 15.24 0.91 1118.79 801.00 1438.00
    PUNJAB CHEM & CROP PROT L 1068.70 20.80 2.95 1310.23 875.90 1664.95
    RALLIS INDIA LTD. 230.90 22.27 2.19 4490.29 216.10 385.60

    Mahamaya Lifesciences Limited shareholding pattern

    Holding
    36.35%
    56.34%
    4.77%
    2.52%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    Mahamaya Lifesciences Limited Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    170.00 -1.73 redarrow
    red-green-graph indicator
    13 Bearish
    3 Bullish
    • 5 Days 173.60
    • 26 Days 172.30
    • 10 Days 173.00
    • 50 Days 171.90
    • 12 Days 172.90
    • 100 Days 170.40
    • 20 Days 172.40
    • 200 Days 167.60
    173.47 PIVOT
    First Support 171.43 First Resistance 175.03 Second Support 169.87 Second Resistance 177.07 Third Support 167.83 Third Resistance 178.63
    RSI 50.87 ADX 27.13 MACD 0.51 Williams % R -34.66 Commodity Channel Index (CCI) 3.86
    Date 2026-07-07 Week 6800.00 Same Day 3600.00 Month 10914.00
    1 Year 0.53 3 Year 0.51
    Over 1 Month
    0.75% down
    Over 1 Year
    49.13% down
    Over 3 Months
    10.50% down
    Over 3 Years
    0.00% down
    Over 6 Months
    -8.94% down
    Over 5 Years
    0.00% down

    Mahamaya Lifesciences Limited Corporate Actions

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Mahamaya Lifesciences Ltd?

    Answer Field

    Mahamaya Lifesciences Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 170.00 as on Jul 08 2026 02:45 PM.

    What is the Market Cap of Mahamaya Lifesciences Ltd Share?

    Answer Field

    The market cap of Mahamaya Lifesciences Ltd for NSE ₹ 0.00 & for BSE ₹ 397.90 as on Jul 08 2026 02:45 PM.

    What is the 52 Week High and Low of Mahamaya Lifesciences Ltd?

    Answer Field

    The 52 Week High and Low of Mahamaya Lifesciences Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 205.05 and ₹ 111.00.

    What is 1 year return for Mahamaya Lifesciences Ltd?

    Answer Field

    The 1 year returns on the stock has been 49.13%.

    What is the P/E Ratio of Mahamaya Lifesciences Ltd Share?

    Answer Field

    As on Jul 08 2026 02:45 PM the price-to-earnings (PE) ratio for Mahamaya Lifesciences Ltd share is 24.23.

    What is the PB ratio of Mahamaya Lifesciences Ltd Share?

    Answer Field

    As on Jul 08 2026 02:45 PM, the price-to-book (PB) ratio for Mahamaya Lifesciences Ltd share is 52.39.

    How to Buy Mahamaya Lifesciences Ltd Share?

    Answer Field

    You can trade in Mahamaya Lifesciences Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Mahamaya Lifesciences Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Mahamaya Lifesciences Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Mahamaya Lifesciences Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |